(Q51856043)

14 April 2018

title

Chronic tocainide therapy for refractory high-grade ventricular arrhythmias. (English)

1 reference

14 April 2018

5

Ockene IS

1 reference

14 April 2018

author name string

Haffajee CI

1

1 reference

14 April 2018

Sacks GM

2

1 reference

14 April 2018

Alpert JS

3

1 reference

14 April 2018

Howe JP 3rd

4

1 reference

14 April 2018

Paraskos JA

6

1 reference

14 April 2018

Dalen JE

7

1 reference

14 April 2018

publication date

1 February 1983

1 reference

14 April 2018

published in

Clinical Cardiology

1 reference

14 April 2018

volume

6

1 reference

14 April 2018

issue

2

1 reference

14 April 2018

page(s)

72-78

1 reference

14 April 2018

Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960060206

Long-term tocainide therapy for ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960060206

Limitations of the Lown grading system for study of human ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960060206

7 January 2021

Assessment of long-term antiarrhythmic therapy: Studies on the long-term efficacy and toxicity of tocainide

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960060206

7 January 2021

Contribution of ambulatory electrocardiographic monitoring to antiarrhythmic management

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960060206

7 January 2021

Electrophysiologic properties of a new antiarrhythmic drug—Tocainide

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960060206

7 January 2021

Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960060206

7 January 2021

Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960060206

7 January 2021

Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960060206

7 January 2021

Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960060206

7 January 2021

Suppression of ventricular ectopic depolarizations by tocainide

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960060206

7 January 2021

New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960060206

7 January 2021

Identifiers

DOI

10.1002/CLC.4960060206

1 reference

14 April 2018

1 reference

14 April 2018